2026-01-20 - Analysis Report
### AbbVie Stock Report
#### Company Overview
AbbVie is a multinational pharmaceutical company that develops and markets a range of products for various diseases and conditions.

### Return Rate Comparison
* Cumulative return of review stock: 175.47%
* Cumulative return of comparison stock (S&P 500, VOO): 93.30%
* Divergence: 82.20

### Alpha, Beta Analysis
| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 50.0% | 16.0% | 46.0% | 1.0 | 162.9B |
| 2017-2019  | 42.0% | 21.6% | 24.0% | 1.1 | 156.5B |
| 2018-2020  | 4.0% | 21.6% | -17.0% | 0.8 | 189.4B |
| 2019-2021  | 61.0% | 20.5% | 18.0% | 0.7 | 239.3B |
| 2020-2022  | 66.0% | 18.5% | 68.0% | 0.6 | 285.6B |
| 2021-2023  | 45.0% | 18.5% | 44.0% | 0.4 | 273.9B |
| 2022-2024  | 37.0% | 18.9% | 18.0% | 0.3 | 314.1B |
| 2023-2025  | 99.0% | 18.9% | 37.0% | 0.3 | 403.8B |

### Recent Stock Price Fluctuations
* Close: $214.35
* Last-market: -0.31% decrease
* 5-day SMA: $218.76
* 20-day SMA: $225.01
* 60-day SMA: $225.80

### RSI, PPO Index Indicators
* Market Risk Indicator (MRI): 0.80 (Medium Investment)
* RSI: 34.11
* PPO: -0.56
* Expected Return (%): 40.20%
* Recent relative divergence change: -2.80 (worsening)
* 7-day Rank change: -4 (rank down)
* 7-day Dynamic Expected Return change: 4.00 (improving)

### Recent News & Significant Events
* AbbVie (ABBV) Stock Dips While Market Gains: Key Facts - Yahoo Finance
* Could Buying This Stock Today Pay Off Big Over the Next 5 Years? - The Motley Fool
* AbbVie (ABBV) Stock Falls Amid Market Uptick: What Investors Need to Know - Nasdaq
* AbbVie Call Options Spike 2,599%: Tracking the Big Bet - MarketBeat
* The Smartest Dividend Stocks to Buy in 2026 With $1,000 Right Now -- Including Realty Income and AbbVie - The Globe and Mail
* AbbVie: Rocky Near-Term, Positive Long-Term (NYSE:ABBV) - Seeking Alpha

### Analyst Opinions
```text
Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 1.93 (~Buy)
- Opinions: 27
- Target Price (avg/high/low): 245.04 / 289.00 / 184.00
```

### Comprehensive Analysis
Based on the provided data, AbbVie's stock has shown significant fluctuations in the past, with a cumulative return of 175.47% compared to the S&P 500's 93.30%. The divergence between the two stocks is 82.20, indicating a relatively high level of divergence.

The Alpha, Beta analysis shows a range of performance across different time periods, with a general trend of increasing return rates and beta values over time.

Recent stock price fluctuations indicate a decrease in stock price, with a last-market decrease of -0.31%. The moving averages are currently above the current stock price, indicating a potential long-term buy.

RSI and PPO indicators suggest a bearish trend, with a recent relative divergence change of -2.80 and a PPO value of -0.56. However, the Market Risk Indicator is 0.80, indicating a medium level of risk.

Overall, the stock seems to be in a bearish trend, but the expected return rate is relatively high at 40.20%. It is essential to consider the recent news and significant events, as well as the analyst opinions, when making investment decisions.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.